These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incidence of Chronic Obstructive Pulmonary Disease in People With Human Immunodeficiency Virus and Their Parents and Siblings in Denmark. Ronit A; Omland LH; Kronborg G; Pedersen G; Nielsen L; Mohey R; Wiese L; Obel N; Ahlström MG J Infect Dis; 2022 Feb; 225(3):492-501. PubMed ID: 34260725 [TBL] [Abstract][Full Text] [Related]
4. HIV and chronic obstructive pulmonary disease: is it worse and why? Morris A; George MP; Crothers K; Huang L; Lucht L; Kessinger C; Kleerup EC; Proc Am Thorac Soc; 2011 Jun; 8(3):320-5. PubMed ID: 21653535 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of emphysema in people with HIV. Kreniske JS; Kaner RJ; Glesby MJ Expert Rev Respir Med; 2023; 17(10):873-887. PubMed ID: 37848398 [TBL] [Abstract][Full Text] [Related]
7. Chronic Lung Disease in HIV Patients. Neri S; Leung J; Besutti G; Santoro A; Fabbri LM; Guaraldi G AIDS Rev; 2018; 20(3):150-157. PubMed ID: 30264824 [TBL] [Abstract][Full Text] [Related]
8. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Madeddu G; Fois AG; Calia GM; Babudieri S; Soddu V; Becciu F; Fiori ML; Spada V; Lovigu C; Mannazzu M; Caddeo A; Piras B; Pirina P; Mura MS Infection; 2013 Apr; 41(2):347-53. PubMed ID: 22971938 [TBL] [Abstract][Full Text] [Related]
9. HIV and COPD: a conspiracy of risk factors. Lalloo UG; Pillay S; Mngqibisa R; Abdool-Gaffar S; Ambaram A Respirology; 2016 Oct; 21(7):1166-72. PubMed ID: 27237114 [TBL] [Abstract][Full Text] [Related]
10. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society. Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455 [TBL] [Abstract][Full Text] [Related]
11. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Yang IA; Jenkins CR; Salvi SS Lancet Respir Med; 2022 May; 10(5):497-511. PubMed ID: 35427530 [TBL] [Abstract][Full Text] [Related]
12. Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects. Raynaud C; Roche N; Chouaid C Respir Res; 2011 Sep; 12(1):117. PubMed ID: 21884608 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J; Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248 [TBL] [Abstract][Full Text] [Related]
14. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies. Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer. Forder A; Zhuang R; Souza VGP; Brockley LJ; Pewarchuk ME; Telkar N; Stewart GL; Benard K; Marshall EA; Reis PP; Lam WL Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769181 [TBL] [Abstract][Full Text] [Related]
17. Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function. Yang L; Dunlap DG; Qin S; Fitch A; Li K; Koch CD; Nouraie M; DeSensi R; Ho KS; Martinson JJ; Methé B; Morris A Am J Respir Crit Care Med; 2020 Feb; 201(4):445-457. PubMed ID: 31682463 [No Abstract] [Full Text] [Related]
18. Chronic Obstructive Pulmonary Disease Prevalence and Associated Factors in a Setting of Well-Controlled HIV, A Cross-Sectional Study. Kayongo A; Wosu AC; Naz T; Nassali F; Kalyesubula R; Kirenga B; Wise RA; Siddharthan T; Checkley W COPD; 2020 Jun; 17(3):297-305. PubMed ID: 32462945 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts. Gingo MR; Balasubramani GK; Rice TB; Kingsley L; Kleerup EC; Detels R; Seaberg EC; Greenblatt RM; Holman S; Huang L; Sutton SH; Bertolet M; Morris A BMC Pulm Med; 2014 Apr; 14():75. PubMed ID: 24884738 [TBL] [Abstract][Full Text] [Related]